This site is intended for healthcare professionals only
LoginRegister
Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer PipelineGilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline
Dr ReddyDr Reddy's Divests Svaas Wellness Stake to Enspirit for Rs 2.23 Crore
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day ExclusivityAurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity
USFDA Approves Alembics Dapagliflozin Tablets, Grants 180-Day ExclusivityUSFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity
UP Fake Degree Scam: 7,000+ Bogus B Pharma Certificates Sold Across DistrictsUP Fake Degree Scam: 7,000+ Bogus B Pharma Certificates Sold Across Districts
2.5 Million Jobs by 2030 in Pharma, Healthcare as Sector Shifts to Skill-Led Growth: Report2.5 Million Jobs by 2030 in Pharma, Healthcare as Sector Shifts to Skill-Led Growth: Report
Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US MarketWegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market
AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer TrialAstraZeneca's Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial
Granules Indias US Arm Gets 4 USFDA ObservationsGranules India's US Arm Gets 4 USFDA Observations
NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026
Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to AppealZydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal
Rajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active IngredientRajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active Ingredient
X